Table 5.
Cytotoxicity of Arglabin and Derivatives Towards Cancer Cell Lines
| Cell line a | 203 | 205 | 208 | 209 | 210 | 211 | 212 |
|---|---|---|---|---|---|---|---|
| 515A2 (melanoma) | 6.72 | 5.54 | 16.9 | 16.9 | 13.2 | 14.3 | 15.0 |
| A431 (cervical) | 4.48 | 5.19 | 12.8 | 13.6 | 16.9 | 18.9 | 4.40 |
| A549 (lung) | 2.21 | 1.95 | 12.8 | 10.1 | 4.76 | 4.76 | 15.7 |
| HT-29 (colon) | 7.00 | 10.8 | 18.6 | 17.8 | 16.2 | 8.1 | 15.1 |
| MCF-7 (breast) | 2.33 | 1.85 | 17.3 | 16.9 | 13.4 | 16.9 | 15.1 |
IC50 values reported in μM